Sort
172,184 grants matching “inflammation”
Harnessing Single Cell Epigenome-wide profiling of Myeloid cells to Compare and Contrast Alzheimer's from HIV-Associated Cognitive Dysfunction
$783,639Lishomwa C Ndhlovu · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · AG
Natural History of C. trachomatis urogenital and rectal infections
$783,622Deborah Anne Dean · University Of California, San Francisco · R01 · FY2024 · AI
Remotely Monitored, Mobile health-supported High Intensity Interval Training after COVID-19 Critical Illness (REMM HIIT-Covid19)
$783,550Paul E Wischmeyer · Duke University · R01 · FY2025 · HD
Imaging and Molecular Phenotyping of Cystic Fibrosis Lung Disease
$783,539Zackary I Cleveland · Cincinnati Childrens Hosp Med Ctr · R01 · FY2023 · HL
The Impact of Tolerance in the Newborn on Lentiviral Infection
$783,538Joseph M McCune · University Of California, San Francisco · R01 · FY2010 · AI
Testing practical microbicides in macaques
$783,535Ronald S. Veazey · Weill Medical Coll Of Cornell Univ · U19 · FY2010 · AI
Hydrogel-enabled self-assembled human brain organoids for neurotoxicity applications
$783,533Connie S Lebakken · Stem Pharm, Inc. · R44 · FY2022 · ES
Mechanisms of myocarditis and progressive cardiac fibrosis in chronic Trypanosoma cruzi infection.
$783,532Kathryn Marie Jones · Baylor College Of Medicine · R01 · FY2022 · AI
Management of Mucositis with GM-CSF
$783,492University Of California San Francisco · R01 · FY2003 · CA
Modeling immune impairments and pathogenesis in novel humanized mice for HBV-HIV co-infection
$783,487Lishan Su · Univ Of North Carolina Chapel Hill · R01 · FY2019 · AI
Calciprotein Particles and Vascular Calcification in Patients with Chronic Kidney Disease
$783,483Wei Chen · Albert Einstein College Of Medicine · R01 · FY2024 · HL
New Approach For The Treatment of Asthma
$783,436Johns Hopkins University · R01 · FY2003 · HL
Bioactive Metabolites Modulate Immune-Related Adverse Events in Cancer Immunotherapy
$783,417Sonia Sharma · La Jolla Institute For Immunology · R01 · FY2021 · CA
Characterize neuronal and glial cell-specific vulnerability to proteinopathies in Alzheimer's disease using multimodal single-nuclei genomic and epigenomic approaches
$783,415Feixiong Cheng · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · AG
Immunoregulation by indoleamine 2,3-dioxygenases in tuberculosis
$783,413John R. Chan · Rbhs-New Jersey Medical School · R01 · FY2022 · AI
Multiparametric MRI for the investigation of coronary microvascular disease
$783,404Frederick H. Epstein · University Of Virginia · R01 · FY2023 · HL
Role of Th17 in Severe and Recurrent C. difficile Infection
$783,404William A Petri · University Of Virginia · R01 · FY2023 · AI
The role of inflammation in the association between diet and Alzheimer's disease
$783,391Yian Gu · Columbia University Health Sciences · R01 · FY2020 · AG
PediatRic sEpsiS induCed MODS: Relationship of Immune-phenotypes and antiBiotic Exposures (PRESCRIBE) study
$783,342Kevin James Downes · Children'S Hosp Of Philadelphia · R01 · FY2024 · HD
Innate Immune Clearance of Host-Adapted Pulmonary Pathogens
$783,334Alice S Prince · Columbia University Health Sciences · R35 · FY2023 · HL
Oral microbiome and periodontal diseases in oral HPV infection among people living with HIV
$783,330Canhua Xiao · Emory University · R01 · FY2023 · DE
Gating mechanisms and pharmacology of P2X receptor channels
$783,281Kenton Swartz · National Institute Of Neurological Disorders And Stroke · ZIA · FY2009 · NS
NINDS Clinical Proteomics Unit
$783,213Jeffrey Kowalak · National Institute Of Neurological Disorders And Stroke · ZIC · FY2021 · NS
Establishment of a causal link between AD and L1 retrotransposons
$783,212Alysson R. Muotri · University Of California, San Diego · R01 · FY2024 · AG
Confirmatory Double-Blind Placebo-Controlled Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons with Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies
$783,201Deanna L Kelly · University Of Maryland Baltimore · R01 · FY2018 · MH